Related Experiment Video
Updated: Oct 22, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients
María Martínez-Urbistondo1, Ángela Gutiérrez-Rojas1, Ane Andrés1
1Internal Medicine Department, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.
Insights
Immunosuppression significantly increases COVID-19 mortality risk. Severe lymphopenia is a key factor in immunocompromised patients, requiring prompt identification for better outcomes.
Area of Science:
- Immunology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) exhibits high mortality in specific patient groups.
- Baseline immunosuppression and severe lymphopenia are potential contributors to COVID-19 mortality in immunocompromised individuals.
Purpose of the Study:
- To analyze the impact of baseline immunosuppression on COVID-19 mortality.
- To investigate the role of severe lymphopenia in immunocompromised COVID-19 patients.
Main Methods:
- Analysis of 1594 COVID-19 patients admitted to a tertiary hospital in Madrid.
- Comparison of epidemiological and clinical data, including severe lymphopenia (<500 lymphocytes/mm³), between immunosuppressed and non-immunosuppressed patients.
Main Results:
- Immunosuppressed patients (10.4%) had higher rates of comorbidities and severe lymphopenia (53% vs 24.1%).
- Immunosuppression was an independent risk factor for mortality (OR: 2.24), with higher mortality rates (27.1% vs 13.5%).
- In immunosuppressed patients, age, ARDS, and severe lymphopenia were associated with increased mortality.
Conclusions:
- Immunosuppression is an independent predictor of mortality in COVID-19 patients.
- Prompt identification of severe lymphopenia is crucial for managing immunocompromised individuals with COVID-19.
Background:
Coronavirus disease 2019 (COVID-19) has a high mortality in certain group of patients. We analysed the impact of baseline immunosuppression in COVID-19 mortality and the role of severe lymphopenia in immunocompromised subjects.
Methods:
We analysed all patients admitted with COVID-19 in a tertiary hospital in Madrid between March 1st and April 30th 2020. Epidemiological and clinical data, including severe lymphopenia (<500 lymphocytes/mm3) during admission, were analysed and compared based on their baseline immunosuppression condition.
Results:
A total of 1594 patients with COVID-19 pneumonia were hospitalised during the study period. 166 (10.4%) were immunosuppressed. Immunocompromised patients were younger (64 vs. 67 years, p = 0.02) but presented higher rates of hypertension, diabetes, heart, neurological, lung, kidney and liver disease (p < 0.05). They showed more severe lymphopenia (53% vs 24.1%, p < 0.001), lower SapO2/FiO2 ratios (251 vs 276, p = 0.02) during admission and higher mortality rates (27.1% vs 13.5%, p < 0.001). After adjustment, immunosuppression remained as an independent factor related to mortality (Odds Ratio (OR): 2.24, p < 0.001). In the immunosuppressed group, age (OR = 1.06, p = 0.01), acute respiratory distress syndrome (ARDS) (OR = 12.27, p = 0.017) and severe lymphopenia (OR = 3.48, p = 0.04) were the factors related to high mortality rate.
Conclusion:
Immunosuppression is an independent mortality risk factor in COVID-19. Severe lymphopenia should be promptly identified in these patients.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

